Brad Rawiller injured in race fall in Bunbury; Evie Girl suffers heart attack at Caulfield


Perth-based Victorian jockey Brad Rawiller faces another extended period on the sidelines, recovering from a suite of injuries sustained in a race fall at Bunbury.

Scans on Wednesday evening at Bunbury regional hospital confirmed a “couple fractures in my back”, broken ribs, a fractured “wing bone” (shoulder blade) and a collapsed lung.

The 42-year-old experienced jockey went down in Race 2 after his mount, Imprudent, blundered about 200m from the winning post.

Rawiller, who was thrown off as Imprudent jolted to the left, narrowly escaped being trodden on by a backmarker.

The 25-time Group 1 jockey, who most recently took out the Perth feature Winterbottom Stakes last year only weeks after his relocation, remained conscious through the ordeal.

Rawiller spent four months on the sidelines from October 2018 recovering from multiple neck and collarbone fractures, along with concussion, sustained in a horror fall at Cranbourne.

The 42-year-old jockey had rides at Pinjarra and Ascot on Thursday and Saturday respectively, but now will not be available.

GIRL’S SAD OUTCOME

Matt Laurie-trained mare Evie Girl could not be saved after collapsing at Caulfield during Race 5, having suffered a suspected heart attack.

The four-year-old daughter of Ocean Park went down about 200m from the finishing post as jockey Noel Callow was in the process of pulling up the distressed galloper.

Evie Girl went into the race as a fancied second favourite.

She settled towards the back of the field in the 1800m benchmark 64 and dropped out of contention as the speed quickened approaching the home bend.



Source link

$38 million available for research into diabetes, heart disease – 16 News


Two new medical research centres will be funded by the Morrison Government to produce rapid improvements in preventing, treating and curing diabetes and cardiovascular disease, and their complications.

The Government will provide $10 million each for the new research centres ($20 million overall), as well as $18 million to support translational research projects.

Expressions of interest are now being sought by MTPConnect for the two research centres and also the first tranche of translational research projects, worth $6 million. There will be opportunities to fund translational research projects using the remaining $12 million in the future.

The funding is drawn from the Government’s Medical Research Future Fund, under its Targeted Translation Research Accelerator, which is managed by MTPConnect.

It will be directed to research projects with the potential to transform diabetes and cardiovascular disease outcomes, and reduce the burden of these diseases on patients, families and the community.

The two research centres will stimulate collaboration across industry, research and clinical organisations.

The Diabetes Research Centre’s translational research, development and implementation science activities will address three priority areas:

·       Diabetic kidney disease.

·       Peripheral neuropathy and diabetic foot syndrome.

·       Short term complications of hypoglycaemia and/or hyperglycaemic hyperosmolar syndrome (HHS) and ketoacidosis.

The priorities for the Cardiovascular Disease Research Centre will be:

·       Coronary artery disease (including angina and MACE)

·       Cardiomyopathy and heart failure

·       Transient ischaemic attack (TIA) and stroke (ischaemic and haemorrhagic).

Through a parallel program of research grants, $6 million will also be made available to develop innovative preventative, diagnostic, therapeutic and disease management products and solutions in priority areas.

The priorities for funding were identified through in-depth consultation with doctors and patients and include chronic kidney disease, cardiac and vascular complications, and mental health of people living with cardiovascular disease and/or diabetes.

The new research funding will build on MTPConnect’s work with its partners—ANDHealth, Medical Device Partnering Program, and UniQuest—to help researchers put their diabetes and cardiovascular disease research results into clinical practice, through mentoring and commercialisation support.

Investing in health and medical research is a priority for the Morrison Government. Research is a key pillar of our plan to make Australia’s health system stronger, more equitable, and more sustainable.

Thank you for dropping by My Local Pages and seeing this article on New South Wales news named “$38 million available for research into diabetes, heart disease – 16 News”. This story was presented by My Local Pages Australia as part of our news aggregator services.

#million #research #diabetes #heart #disease #News



Source link

Finbar breaks ground on Civic Heart



Following years of setbacks and delays, earthworks have started at Finbar’s Civic Heart project in South Perth.

Thank you for dropping in to My Local Pages and checking out this news release regarding current West Australian News called “Finbar breaks ground on Civic Heart”. This post was brought to you by MyLocalPages as part of our news aggregator services.

#Finbar #breaks #ground #Civic #Heart



Source link

Mesoblast holds out hope for heart failure drug


Shares in stem cell biotech Mesoblast jumped nearly 16 per cent after the company said it would pursue approval for its key heart failure drug in the US despite a clinical trial delivering mixed results.

On Monday the company told investors that additional data from the phase 3 trial of its Revascor product showed a “substantial and durable reductions in heart attacks, strokes and cardiac deaths” in patients with chronic heart failure.

Mesoblast shares bounced after a tough end to 2020, when shares were savaged after news its COVID-19 trial was unsuccessful.

The company had trialled Revascor on 537 patients with advanced chronic heart failure and it showed a reduction in mortality rates for heart failure patients. However, last December Mesoblast revealed this trial was unsuccessful in meeting its main stated aim: showing the drug reduced the incidence of trips to hospital for non-fatal heart failure events.

On Monday, the company released updated data from this study to the ASX, arguing that despite missing its main goal in regards to hospitalisations, the research suggested the drug could help reduce deaths of patients where there are few other treatment options.

Thank you for checking this news article involving local and Australian business named “Mesoblast holds out hope for heart failure drug”. This story was shared by MyLocalPages as part of our Australian and international news services.

#Mesoblast #holds #hope #heart #failure #drug



Source link

COVID-19 and the heart: What have we learned?



Early in the pandemic, epidemiologists made a striking observation. Compared to the general population, people with cardiovascular disease (CVD) were more than twice as likely to contract severe forms of COVID-19. In the last six months, death rates from COVID-19 have dropped significantly, but CVD remains a major predictor of poor outcome. What have we learned about heart disease and COVID-19 in that time?

Pre-existing heart conditions and poor metabolic health increase risk of severe COVID-19

As I described in a blog post back in April, some health conditions, like diabetes, increase risk of severe COVID-19 by suppressing the immune system; others, like asthma, increase risk by weakening the lungs. However, in the early months of the pandemic it was not entirely clear how CVD increased the risk of severe COVID-19. We now have two explanations.

The first is that pre-existing heart conditions, such as damaged heart muscle or blocked heart arteries, weaken the body’s ability to survive the stress of the illness. A person with a vulnerable heart is more likely to succumb to the effects of fever, low oxygen levels, unstable blood pressures, and blood clotting disorders — all possible consequences of COVID-19 — than someone previously healthy.

A second explanation relates to poor underlying metabolic health, which is more common in those with heart disease. Poor metabolic health refers to diseases such as type 2 diabetes or prediabetes and obesity, which themselves cause inflammation and risk of blood clots, compounding the effects of COVID-19 and increasing the likelihood of devastating complications of COVID-19.

How does COVID-19 cause heart damage?

The SARS-CoV-2 virus can damage the heart in several ways. For example, the virus may directly invade or inflame the heart muscle, and it may indirectly harm the heart by disrupting the balance between oxygen supply and demand. Heart injury, which may be measured by elevated levels of the enzyme troponin in the bloodstream, has been detected in about one-quarter of patients hospitalized with severe COVID-19 illness. Of these patients, about one-third have pre-existing CVD.

Inflammation of the heart muscle

The majority of people with COVID-19 will have mild symptoms and recover fully. However, about 20% will develop pneumonia, and about 5% will develop severe disease. In the severe form of COVID-19, the body’s immune system overreacts to the infection, releasing inflammatory molecules called cytokines into the bloodstream. This so-called “cytokine storm” can damage multiple organs, including the heart.

Inflammation of the heart muscle, called myocarditis, typically occurs only in patients with advanced COVID-19 disease. Myocarditis can result from direct heart invasion by the virus itself, or more commonly by inflammation caused by cytokine storm. When this occurs, the heart may become enlarged and weakened, leading to low blood pressure and fluid in the lungs. While this severe form of myocarditis is rare, recent studies have suggested that a milder form of heart muscle inflammation may be much more common than previously recognized. A recent study showed that asymptomatic heart inflammation was seen on magnetic resonance imaging in up to three-quarters of patients who had recovered from severe COVID-19.

Increased oxygen demand and decreased oxygen supply lead to heart damage

Fever and infection cause the heart rate to speed up, increasing the work of the heart in COVID-19 patients who develop pneumonia. Blood pressure may drop or spike, causing further stress on the heart, and the resulting increase in oxygen demand can lead to heart damage, especially if the heart arteries or muscle were unhealthy to begin with.

Heart damage is most often caused by heart attacks, which result from the formation of a blood clot in a vulnerable heart artery, blocking delivery of oxygen to the heart muscle. COVID-19-related inflammation raises the risk of this type of heart attack by activating the body’s clotting system and disrupting the blood vessel lining. When inflamed, this lining loses its ability to resist clot formation. These blood clots in the large and small arteries of the heart cut off its supply of oxygen. The increased clotting tendency can also lead to blood clots in the lungs, which can cause a drop in blood oxygen levels. Severe pneumonia drops blood oxygen further. When the oxygen demand exceeds the supply, the heart muscle is damaged.

Finding a silver lining and lowering risk through healthy lifestyle

People with CVD who adopt healthy behaviors can strengthen their defenses against COVID-19 while also reducing the long-term risk from cardiovascular disease itself. This means plenty of physical activity and following a healthy diet like the Mediterranean diet. Cook at home when you can, and walk outdoors with friends if your gym is temporarily closed. Purchase an inexpensive and easy-to-use monitor to measure your blood pressure at home. And continue to follow the CDC’s safety guidelines to wear masks, physically distance, and avoid large gatherings.

The post COVID-19 and the heart: What have we learned? appeared first on Harvard Health Blog.

Thanks for dropping by and checking out this news article about current Healthy Living and related news titled “COVID-19 and the heart: What have we learned?”. This news update is presented by My Local Pages Australia as part of our World sports news services.

#COVID19 #heart #learned



Source link

Sourav Ganguly: Former India captain discharged from hospital after heart attack


Sourav Ganguly is one of India’s most successful captains, winning 21 of 49 Tests

Former India captain Sourav Ganguly has been discharged from hospital after having a heart attack on Saturday.

The 48-year-old president of the Board of Control for Cricket in India (BCCI) developed chest pains while exercising at his home gym and had surgery in Kolkata over the weekend.

Ganguly had an angioplasty, a procedure to unblock a coronary artery.

“I thank the doctors at the hospital for the treatment,” he told fans waiting outside the hospital.

“I am absolutely fine. Hopefully, I will be ready to fly soon.”

Ganguly played 113 Tests and 311 one-day internationals, captaining India in the longest format 49 times between 2000 and 2005.

A left-handed batsman, he scored 7,212 Test runs and scored 16 centuries, before taking over as president of the Indian cricket board in October 2019.

India are currently touring Australia, where the third Test began in Sydney on Thursday.

Thank you for stopping by to visit My Local Pages and seeing this news article involving World Sports and related news titled “Sourav Ganguly: Former India captain discharged from hospital after heart attack”. This news article is posted by MyLocalPages as part of our news aggregator services.

#Sourav #Ganguly #India #captain #discharged #hospital #heart #attack



Source link

Sourav Ganguly suffers heart attack


Sourav’s illness comes amid a speculation of a renewed attempt by the BJP to rope in him as it’s chief ministerial candidate

Kolkata: BCCI president Sourav Ganguly suffered a “mild cardiac arrest” leading to a black out during a fitness session on the treadmill at the gym of his Behala residence in Kolkata on Saturday morning. He was rushed by his wife Dona and elder brother Snehasis at around 1 pm to Woodlands Hospital where he has been admitted to the intensive critical care unit.

The 48-year-old former Indian cricket captain, who have a family history of ischemic heart disease and complained of a chest and back pain on Friday, was found with blockages in his heart, said CEO of the private hospital Dr Rupali Basu. She added, “Sourav underwent angiography and angioplasty in one of three arteries. His condition is stable and conscious now.”

 

Dr Aftab Khan, a cardiologist of the five member-medical board treating Sourav, said, “We will now take a decision how to clear the blockages in the rest two arteries. He is under observation.” Sourav spoke to Dona and their daughter: Sana later. He will be at the hospital at least for the next four-five days.

West Bengal chief minister Mamata Banerjee tweeted, “Sad to hear that @SGanguly99 suffered a mild cardiac arrest and has been admitted to hospital. Wishing him a speedy and full recovery. My thoughts and prayers are with him and his family!” She and several other state ministers visited Sourav later.

“He is fine and smiling. Lying on the bed he rather asked me: how is your health? He is our pride. I do not how it happened to him. I heard he never underwent any test despite being such a big sportsperson of international stature. I was not aware of it. I thank the hospital authorities and doctors for their prompt treatment,” Ms Banerjee said.

 

Sourav’s illness comes amid a speculation of a renewed attempt by the BJP to rope in him as it’s chief ministerial candidate with the Bhoomiputra face for the upcoming West Bengal Assembly Election though he swept away the offer earlier.

Worried about his ill health, union home minister Amit Shah, who shared the dais with him at a cricket event in New Delhi on December 28, inquired about his condition from senior BJP leader Kailash Vijayvargiya who has been in touch with the hospital authorities. Some BJP leaders also visited the hospital.

Governor Jagdeep Dhankhar, whom Sourav met a week ago before meeting Mr Shah, also visited Sourav. Wishing his speedy recovery, he said, “I interacted with him. I am greatly relieved like millions of followers of him all over the world.” Cricket legend Sachin Tendulkar tweeted, “Just got to know about your ailment Sourav. Hope each passing day brings you closer to a full and speedy recovery! Get well soon.”

 

end-of



Source link

Sourav Ganguly: Former India captain stable in hospital after heart attack


Sourav Ganguly is one of India’s most successful captains, winning 21 of 49 Tests

Former India captain Sourav Ganguly is in a stable condition after having a heart attack on Saturday.

The 48-year-old president of the Board of Control for Cricket in India (BCCI) is “responding well to treatment”, the body’s secretary Jay Shah said.

He developed chest pains while exercising and has now had surgery.

Ganguly played 113 Tests and 311 one-day internationals, captaining India in the longest format 49 times between 2000 and 2005.

Doctors said Ganguly had an angioplasty – a procedure to unblock a coronary artery – in hospital in Kolkata and would be monitored for 24 hours.

A left-handed batsman, Ganguly scored 7,212 Test runs and scored 16 centuries.

He is ninth on the all-time ODI run-scorers list with 11,363. He scored 22 hundreds in the 50-over format.

He took over as president of the Indian cricket board in October 2019.

India captain Virat Kohli tweeted: “Praying for your speedy recovery. Get well soon.”





Source link

BCCI president and cricket great Sourav Ganguly in hospital after suspected heart attack


The president of the Indian cricket board Sourav Ganguly has been taken to hospital in Kolkata after a mild heart attack.

Indian media is reporting Ganguly, who led India from 2000-05, was admitted to hospital after complaining of chest pain while working out on Saturday morning. He is reportedly in a stable condition.

There are reports he needs an angioplasty, a procedure which widens the arteries to restore blood flow.

The secretary of the Board of Control for Cricket in India, Jay Shah, provided an update on Twitter.



Source link

Sourav Ganguly hospitalised, news, heart attack, blackout, update, India cricket,


Watch the New Year’s Test between Australia and India LIVE on Fox Cricket, coverage starts Thursday at 9:30am AEDT!

Indian cricket legend Sourav Ganguly was rushed to hospital Saturday after complaining of chest pains, the chief minister in his home state said.

The 48-year-old, who now heads the country’s cricket board, “suffered a mild cardiac arrest and has been admitted to hospital”, tweeted Mamata Banerjee, chief minister of West Bengal.

Ganguly “suffered a blackout” while exercising at his personal gym in the morning and was immediately taken to Woodlands hospital in state capital Kolkata, according to a senior doctor there.





Source link